Prokidney

PROKNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$495.378 M

$1.64 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$69.0M

Loss-making

Shares outstanding

61,540,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#67Eikon TherapeuticsEIKN$502.9M
#68Valneva SEVALN$502.9M
#69ProkidneyPROK$495.4M
#70Ginkgo BioworksDNA$495.2M
#71Kyverna TherapeuticsKYTX$483.9M

Where these numbers come from

Share counts and financials for Prokidney are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.